GLP-1RAs increase natriuresis by inhibiting sodium reabsorption by acting on the Na/H exchanger in the proximal tubule of the kidney [75]
2017-12M-1-006), the National Key Research and Development Program/Prevent and Control Research for Important Non-Communicable Diseases (No
Phase 2 combination trials reported 35-40% discontinuation rates due to GI side effects when both agents were dosed simultaneously
This medicine is recommended for rabbits, horses, poultry, companion animals, and livestock like cattle, goats, and sheep
Conclusion Published clinical trial data paints a consistent picture of the retatrutide adverse event profile and associated risks: GI events are common, dose-dependent, and generally transient , with rates comparable to other GLP-1 class compounds